🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ameloblastoma is the most common benign odontogenic tumor, characterized by...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06819605
Treatments Being Tested
This phase 2 trial will investigate the efficacy and safety of trametinib a...
Status
Completed
Location
Universitair Ziekenhuis Brussel
Start Date
2019-01-28
Trial ID
NCT04059224
Treatments Being Tested
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This is a global, multi-centre, open-label, study of GSK2118436 conducted i...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-04-08
Trial ID
NCT01978236
Treatments Being Tested
The purpose of this study is to find out whether a drug called PDR001, comb...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2020-09-02
Trial ID
NCT04544111
Treatments Being Tested
The aim of the study was to evaluate the effectiveness of combination thera...
Status
Withdrawn
Location
Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of High Medical Technologies
Start Date
2021-01-22
Trial ID
NCT04739566
Treatments Being Tested
This phase II trial studies how well de-escalating the drugs dabrafenib and...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2025-11-07
Trial ID
NCT07110246
Present clinical study will be conducted in China to evaluate the pharmacok...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05
Trial ID
NCT02447939
Treatments Being Tested
The purpose of this study was to evaluate safety and efficacy of the combin...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2017-02-17
Trial ID
NCT02967692
Treatments Being Tested